Why is Ajanta Pharma falling/rising?

As of 29-Jul, Ajanta Pharma Ltd. is experiencing a price increase, currently at Rs 2,827.00, which reflects a rise of 73.35 or 2.66%. The stock has shown a positive trend today, outperforming its sector by 1.25% and reversing a two-day decline. It reached an intraday high of Rs 2,828.75, and is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant increase in investor participation, with delivery volume rising by 136.61% compared to the 5-day average. Over the past week, the stock has gained 3.53%, while it has outperformed the benchmark Sensex, which has declined by 1.03% over the same period.
In the broader market context, Ajanta Pharma's recent performance contrasts sharply with the benchmark, as it has delivered a positive return while the Sensex has fallen. The company benefits from high management efficiency, evidenced by a return on equity (ROE) of 22.06% and a low debt-to-equity ratio, which supports its stability. Positive financial results, including the highest net sales and PBDIT in the last quarter, further bolster investor confidence. With high institutional holdings at 26.36%, the stock is viewed favorably by knowledgeable investors, contributing to its consistent returns over the past three years, including a 16.46% gain in the last year alone.